GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $212,000 | -5.8% | 6,296 | +2.7% | 0.09% | -7.0% |
| Q4 2020 | $225,000 | -2.2% | 6,131 | 0.0% | 0.10% | -11.5% |
| Q3 2020 | $230,000 | +0.4% | 6,131 | +9.1% | 0.11% | -16.9% |
| Q2 2020 | $229,000 | -53.5% | 5,618 | -54.3% | 0.14% | -21.4% |
| Q2 2019 | $492,000 | +72.0% | 12,293 | +79.7% | 0.17% | +6.1% |
| Q1 2019 | $286,000 | +40.2% | 6,842 | +28.1% | 0.16% | +27.3% |
| Q4 2018 | $204,000 | – | 5,342 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |